icon-folder.gif   Conference Reports for NATAP  
 
  HIV Drug Therapy Glasgow
November 2-6, 2014
Glasgow, UK
Back grey_arrow_rt.gif
 
 
 
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis and Safety Profile - oral presentation
 
 
  Reported by Jules Levin
HIV Glasgow 2014 Nov 2-6
 
J Lalezari,1 C Brinson,2 GH Latiff,3 J Echevarría,4 M Thompson,5 S Trevino-Pérez,6 JR Bogner,7 D Stock,8 SR Joshi,8 GJ Hanna,9
M Lataillade8
for the AI438011 study team
 
1. Quest Clinical Research, San Francisco, CA, US; 2. Central Texas Clinical Research, Austin, TX, USA; 3. Maxwell Clinic, Durban, South Africa; 4. Hospital Nacional Cayetano Heredia, Lima, Peru; 5. AIDS Research Consortium of Atlanta, Atlanta, USA; 6. Mexico Centre for Clinical Research, Mexico City, Mexico; 7. Hospital of the University of Munich, Munich, Germany 8. Bristol-Myers Squibb, Wallingford, CT, USA; 9. Bristol-Myers Squibb, Princeton, NJ, USA

Glasgow1.gif

Glasgow2.gif

Glasgow3.gif

Glasgow4.gif

Glasgow5.gif

Glasgow6.gif

Glasgow7.gif

Glasgow8.gif

Glasgow9.gif

Glasgow10.gif

Glasgow11.gif